A
$ Value
$0
Shares
6,449
Price
$0
Filed
Jun 13
Insider
Name
Dai, Weili
Title
—
CIK
0001134140
Roles
Director
Transaction Details
Transaction Date
2025-06-11
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
13,663
Footnotes
Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2024 Equity Incentive Plan, which will vest on the earlier of (i) June 11, 2026 or (ii) the date of the Issuer's 2026 annual meeting of stockholders. | Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders.
Filing Info
Dai, Weili's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-06-11 | ASTH | A | $0 |
Other Insiders at ASTH (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Lam Thomas S. | — | — | 2026-04-06 |
|
Sim Kenneth T.
Executive Chairman
|
— | — | 2026-04-06 |
|
Sim Brandon
CEO and President
|
— | — | 2026-04-06 |
|
Kumar Dinesh M.
Chief Medical Officer
|
— | — | 2026-04-01 |
|
Sobotka Glenn
Chief Accounting Officer
|
— | — | 2026-03-26 |
|
Basho Chandan
COO and CFO
|
— | — | 2026-04-14 |